Drug profile · INN
glucarpidase
VORAXAZE
glucarpidase (VORAXAZE) is a methotrexate hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
Drug details — glucarpidase
- US status
- approved
- Class
- Various (V03)
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
glucarpidase (VORAXAZE) is a methotrexate hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Methotrexate hydrolytic enzyme
Primary target: Methotrexate
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is glucarpidase?
glucarpidase (VORAXAZE) is a methotrexate hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for glucarpidase?
VORAXAZE is a marketed brand name for glucarpidase. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of glucarpidase?
glucarpidase has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.